BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Clofibrate
,
rs4950928
,
KLK3
,
Apoptosis
,
Leukemia
,
Hypothalamus
,
Personalized medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
positive regulation of compound eye pigmentation
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Edetic Acid
pdf protein, Drosophila
Light
X-Rays
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Clk
TP53
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
D. melanogaster embryos Smaug mutant, free or polysome associated mRNAs
Drosophila life cycle - embryo, larva, pupa and adult stages
Functional constraints on the integrity of an ultra conserved region in Drosophila
Testicular gene expression profiles of Drosophila species and hybrid species
Notch targets in DmD8 and KC Drosophila cell lines
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for positive regulation of compound eye pigmentation
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Intermittent Selumetinib for Uveal Melanoma
Early Administration of the Lutein/Zeaxanthin in Premature Newborns
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ